Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states.

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Several states have reached a $7 billion settlement with Purdue Pharma based on the Sackler family's role in creating the opioid crisis, New York Attorney General Letitia James announced today. The ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Purdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total of $6.5 billion, New York Attorney General Letitia James said Thursday.

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.

Purdue Pharma and the Sackler family that controls the major prescription opioids manufacturer have agreed to a $7.4 billion settlement with West Virginia and 13 other states due to fueling the ...